In Vitro and In Vivo Effects of IGF-1 Delivery Strategies on Tendon Healing: A Review.
Iris MiescherJulia RieberMaurizio CalcagniJohanna BuschmannPublished in: International journal of molecular sciences (2023)
Tendon injuries suffer from a slow healing, often ending up in fibrovascular scar formation, leading to inferior mechanical properties and even re-rupture upon resumption of daily work or sports. Strategies including the application of growth factors have been under view for decades. Insulin-like growth factor-1 (IGF-1) is one of the used growth factors and has been applied to tenocyte in vitro cultures as well as in animal preclinical models and to human patients due to its anabolic and matrix stimulating effects. In this narrative review, we cover the current literature on IGF-1, its mechanism of action, in vitro cell cultures (tenocytes and mesenchymal stem cells), as well as in vivo experiments. We conclude from this overview that IGF-1 is a potent stimulus for improving tendon healing due to its inherent support of cell proliferation, DNA and matrix synthesis, particularly collagen I, which is the main component of tendon tissue. Nevertheless, more in vivo studies have to be performed in order to pave the way for an IGF-1 application in orthopedic clinics.
Keyphrases
- growth hormone
- pi k akt
- binding protein
- mesenchymal stem cells
- cell proliferation
- anterior cruciate ligament reconstruction
- end stage renal disease
- rotator cuff
- cell therapy
- endothelial cells
- systematic review
- ejection fraction
- chronic kidney disease
- signaling pathway
- newly diagnosed
- peritoneal dialysis
- cell cycle
- circulating tumor
- bone marrow
- umbilical cord
- wound healing
- anti inflammatory
- induced pluripotent stem cells
- circulating tumor cells